| Trial ID: | L0194 |
| Source ID: | NCT02009592
|
| Associated Drug: |
Rifaximin
|
| Title: |
Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver|Steatohepatitis
|
| Interventions: |
Drug: Rifaximin
|
| Outcome Measures: |
Drop in the levels of pro-inflammatory cytokines and increase in anti-inflammatory cytokines
|
| Sponsor/Collaborators: |
Bezmialem Vakif University
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
42
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
June 2013
|
| Completion Date: |
February 2014
|
| Results First Posted: |
--
|
| Last Update Posted: |
May 16, 2014
|
| Locations: |
Bezmialem Vakif University, Istanbul, Turkey
|
| URL: |
https://ClinicalTrials.gov/show/NCT02009592
|
